Reminder: Invitation to Roche’s virtual event on key hematology data presented at ASH 2021

Investor Update Reminder: Invitation to Roche's virtual event on key hematology data presented at ASH 2021

We are pleased to invite investors and analysts to participate in our virtual event on Wednesday,
15 December, 2021, highlighting Roche data presented at the virtual American Society of Hematology (ASH) 63^rd Annual Meeting, from 11-14^th December.

16:00 - 17:30 CET / 15:00 - 16:30GMT
10:00 - 11:30 am EST / 7:00 - 8:30 am PST

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers).

Agenda:

Welcome
Karl Mahler, Head of Investor Relations

Hematology franchise overview
Peter Ahnesorg, Franchise Head Hematology

Review of key clinical data presented at ASH: Hemlibra, mosun,glofit,cevostamab
Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development

Presentation of POLARIX data
Franck Morschhauser, MD, PhD, Professor of Hematology, University of Lille; President of LYSA, LYSARC

Q&A

The slides will be available for download at 15:00 CET on the day of the event. > click here

Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an email to [e-mail].

A replay of the event will be available via >ir.roche.com

*privacy notice

Best regards,
Karl Mahler Head of Investor Relations	Loren Kalm Head of Investor Relations, North America
Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]
Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]	Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]
Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]